---
title: "603858.SH (603858.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603858.SH/news.md"
symbol: "603858.SH"
name: "603858.SH"
parent: "https://longbridge.com/en/quote/603858.SH.md"
datetime: "2026-05-20T00:27:12.259Z"
locales:
  - [en](https://longbridge.com/en/quote/603858.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603858.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603858.SH/news.md)
---

# 603858.SH (603858.SH) — Related News

### [BUCHANG PHARMA: The holding subsidiary signs a cooperation agreement on intellectual property for the influenza vaccine project](https://longbridge.com/en/news/286873725.md)
*2026-05-19T07:53:22.000Z*
> BUCHANG PHARMA's holding subsidiary signed an intellectual property cooperation agreement for the influenza vaccine proj

### [Goodbye to losses, distributing 600 million! BUCHANG PHARMA strikes back for traditional Chinese medicine companies?](https://longbridge.com/en/news/286503988.md)
*2026-05-15T03:38:20.000Z*
> BUCHANG PHARMA achieved a net profit of 361 million yuan in 2025, successfully reversing the loss of 554 million yuan in

### [BUCHANG PHARMA's subsidiary plans to sign an intellectual property cooperation agreement](https://longbridge.com/en/news/286415007.md)
*2026-05-14T12:16:05.000Z*
> BUCHANG PHARMA's subsidiary Zhejiang Huapai Biopharmaceutical Co., Ltd. plans to sign a cooperation agreement on intelle

### [Who earned the most? The ranking of net profits of traditional Chinese medicine listed companies in 2025 is revealed](https://longbridge.com/en/news/286340296.md)
*2026-05-14T01:25:12.000Z*
> Who earned the most? The ranking of net profits of traditional Chinese medicine listed companies in 2025 is revealed

### [SINOPHARM and BUCHANG PHARMA have reached a comprehensive strategic cooperation](https://longbridge.com/en/news/285802244.md)
*2026-05-09T07:34:21.000Z*
> According to SINOPHARM news, recently, SINOPHARM and BUCHANG PHARMA reached a strategic signing in Xi'an, deciding to fu

### [BUCHANG PHARMA: The holding subsidiary Zhejiang Tianyuan participates in the "Multifunctional Antibody Preventive HIV Vaccine Research and Development" project](https://longbridge.com/en/news/285705100.md)
*2026-05-08T10:17:34.000Z*
> BUCHANG PHARMA announced that its holding subsidiary, Zhejiang Tianyuan Biopharmaceutical Co., Ltd., recently received a

### [BUCHANG PHARMA: The 1% equity transfer of the holding subsidiary has been completed, and Wang Minxi is the acquirer](https://longbridge.com/en/news/282963901.md)
*2026-04-16T08:28:44.000Z*
> BUCHANG PHARMA announced that Ding Li, the original shareholder of its controlling subsidiary BUCHANG CHANGYAN, has resi

### [BUCHANG PHARMA: Yangzheng Heji has obtained the drug registration certificate in Malaysia](https://longbridge.com/en/news/282006762.md)
*2026-04-08T08:57:03.000Z*
> BUCHANG PHARMA announced that its wholly-owned subsidiary Yangling Buchang Pharmaceutical Co., Ltd. has obtained the dru